ADVANCEMENTS AND PATENTS IN PHARMACEUTICAL SUSPENSION TECHNOLOGIES 

Journal Title: Journal of Biological and Scientific Opinion - Year 2013, Vol 1, Issue 4

Abstract

Suspensions are solid-liquid dispersion and defined as heterogeneous biphasic liquid dosage form of medicaments in which continuous or external phase is usually a liquid or semisolid and the dispersed or internal phase is made up of particulate matter that is essentially insoluble in, but dispersed through, the continuous phase. They require suspending agents to suspend the fine particles of dispersed phase, proper wetting agents (surfactants), viscosity increasing agents to improve the stability of preparation and suitable preservatives in preparation. Suspensions are generally taken orally or by parenteral route and also used for external applications. Suspension should have heterogeneous nature and product should be resistant to microbial contamination. Various types of suspension are available in pharmaceuticals like oral, parenteral, ophthalmic and suspension for external uses. Several advancements in suspension technologies viz nanosuspension, taste masked suspension, sustained release suspension, aqueous suspension etc. are discussed in detail. Patents related to these advancements are also mentioned in this article of previous 39 years (from 2012 to 1975). This article emphasise on the general introduction of suspension, their types, recent advancements and patents related to these advancements. 

Authors and Affiliations

Sushma Gedar , Mahesh Kataria, Ajay Bilandi , Ruchi Taneja

Keywords

Related Articles

CURRENT TRENDS IN AYURVEDIC MANAGEMENT OF CEREBRAL PALSY IN CHILDREN 

Cerebral palsy is most common motor disability affecting a large paediatric population worldwide. Children affected with the disease presents with developmental delay and motor deficits and may have one or more associate...

ROLE OF AYURVEDIC MEDICINE AND LEECH THERAPY IN MANAGEMENT OF DEEP VEIN THROMBOSIS: A CASE STUDY 

Panchakarma is a therapeutic way of eliminating toxic elements from the body. According to Sushruta, Panchakarma include five Shodhana (purification) process or therapies in which Raktamokshana (bloodletting) is one amon...

DEEPER INSIGHT OF SUBTLE MIND IN AYURVEDA 

Mind is an inseparable entity in the living body. It is the basic factor responsible for acquiring knowledge and for performing actions. The three Guna (Qualities) of Mana (mind) viz. Satva, Rajas and Tamas have been con...

PRODRUG DESIGN FOR OPTIMIZED DRUG DELIVERY SYSTEMS 

The term prodrug refers to a pharmacologically inactive compound that is converted to an active drug by a metabolic bio transformation. Prodrug design may be useful in circumventing problems associated such as Solubility...

MELATONIN RECEPTOR (MT1 AND MT2) PROTEINS EXPRESSION IN THYROID GLAND AND LEVEL OF THYROXIN (T4), THYROTROPIN (TSH) HORMONE DURING PROGRESSION OF AGE IN MALE SWISS ALBINO MICE  

Advancement of age is related with a progressive declining in most of the physiological activities. The activity of thyroid gland is also disturbed with increment of age in the organism. Melatonin regulates most of the p...

Download PDF file
  • EP ID EP151952
  • DOI 10.7897/2321–6328.01420
  • Views 104
  • Downloads 0

How To Cite

Sushma Gedar, Mahesh Kataria, Ajay Bilandi, Ruchi Taneja (2013). ADVANCEMENTS AND PATENTS IN PHARMACEUTICAL SUSPENSION TECHNOLOGIES . Journal of Biological and Scientific Opinion, 1(4), 372-380. https://www.europub.co.uk/articles/-A-151952